{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:33:23Z","timestamp":1774668803921,"version":"3.50.1"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background and Objective<\/jats:title><jats:p>White matter lesions (WMLs) are imaging changes in MRI of cerebral small vessel disease associated with vascular risk factors, increasing the risk of dementia, depression, and stroke. Aldosterone (ALD) or activation of mineralocorticoid receptor (MR) causes cerebrovascular injury in a mouse model. We aimed to analyze the relationship between ALD and WMLs in a population with hypertension.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective review of all patients screened for causes of secondary hypertension. We enrolled 547 patients with WMLs and matched these to controls without WMLs at a 1:1 ratio. White matter lesion load was assessed by using a modified Scheltens\u2019 scale.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the analytic sample (N = 1,094) with ages ranging from 30 to 64 years, 62.2% were male. We divided plasma ALD concentration (PAC), plasma renin activity (PRA), and ALD\u2013renin ratio (ARR) into the third tertile (Q3), second tertile (Q2), and first tertile (Q1). We also analyzed them simultaneously as continuous variables. Multivariate logistic regression analysis showed that participants in Q3 (&amp;gt;17.26 ng\/dl) of PAC (OR 1.59, 95% CI 1.15, 2.19), Q3 (&amp;lt;0.80 ng\/dl) of PRA (OR 2.50, 95% CI 1.81, 3.44), and Q3 (&amp;gt;18.59 ng\/dl per ng\/ml*h) of ARR (OR 2.90, 95% CI 2.10, 4.01) had a significantly higher risk of WMLs than those in Q1 (&amp;lt;12.48) of PAC, Q1 (&amp;gt;2.19) of PRA, and Q1 (&amp;lt;6.96) of ARR. In linear regression analysis, we separately analyzed the correlation between the modified Scheltens\u2019 scale score and log(PAC) (\u03b2 = 2.36; 95% CI 1.30, 3.41; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), log(PRA) (\u03b2 = \u22121.76; 95% CI \u22122.09, \u22121.43; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), and log(ARR) (\u03b2 = 1.86; 95% CI 1.55, 2.17; <jats:italic>p<\/jats:italic> &amp;lt; 0.001), which were all significantly correlated with white matter lesion load, after adjusting for confounding factors. Simple mediation analyses showed that systolic blood pressure (SBP) or diastolic blood pressure (DBP) mediated \u22123.83% or \u22122.66% of the association between PAC and white matter lesion load, respectively. In stratified analyses, there was no evidence of subgroup heterogeneity concerning the change in the risk of WMLs (<jats:italic>p<\/jats:italic> &amp;gt; 0.05 for interaction for all).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Higher PAC, especially in PAC &amp;gt;17.26 ng\/dl, increased the risk of WMLs. PAC was positively associated with white matter lesion load independent of SBP or DBP.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.753074","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:39:51Z","timestamp":1637228391000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Positive Association Between Plasma Aldosterone Concentration and White Matter Lesions in Patients With Hypertension"],"prefix":"10.3389","volume":"12","author":[{"given":"Yujuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulalibieke","family":"Heizhati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deilian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guijuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuerguli","family":"Maimaiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging Standards for Research Into Small Vessel Disease and ITS Contribution to Ageing and Neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s1202l-015-9260-v","article-title":"Automatic Detection of White Matter Hyperintensities in Healthy Aging and Pathology Using Magnetic Resollauce Knagmg: A Review","volume":"13","author":"Caligiuri","year":"2015","journal-title":"Neuromformatics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral Small Vessel Disease: From Pathogenesis and Clinical Characteristics to Therapeutic Challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.204685","article-title":"Heterogeneity of Small Vessel Disease: A Systematic Review of MRI and Histopathology Correlations","volume":"82","author":"Gouw","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000505","article-title":"Presence and Progression of White Matter Hyperintensities and Cognition: A Meta-Analysis","volume":"82","author":"Kloppenborg","year":"2014","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.018101","article-title":"Neuropathology of White Matter Lesions,  Blood-Brain Barrier Dysfunction, and Dementia","volume":"48","author":"Hainsworth","year":"2017","journal-title":"Stroke"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150306","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) White Matter Changes Are Associated With Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer\u2019s Disease","volume":"49","author":"Coutu","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jpsychires.2014.05.005","article-title":"White Matter Lesions and Depression: A Systematic Review and Meta-Analysis","volume":"56","author":"Wang","year":"2014","journal-title":"J Psychiatr Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000132193.35955.69","article-title":"Cardiovascular Health Study Collaborative Research Group. White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke","volume":"35","author":"Kuller","year":"2004","journal-title":"Stroke"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glt072","article-title":"Rapid Buildup of Brain White Matter Hyperintensities Over 4 Years Linked Toambulatory Blood Pressure, Mobility, Cognition, and Depression in Old Persons","volume":"68","author":"Wolfson","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/STROKEAHA.109.566992","article-title":"Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study","volume":"41","author":"McNeil","year":"2010","journal-title":"Stroke"},{"key":"B12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ageing\/afx102","article-title":"Increased Diastolic Blood Pressure Is Associated With MRI Biomarkers of Dementia-Related Brain Pathology in Normative Ageing","volume":"47","author":"McNeil","year":"2018","journal-title":"Age Ageing"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02735","article-title":"Blood Pressure, Internal Carotid Artery Flow Parameters, and Age-Related White Matter Hyperintensities","volume":"63","author":"Aribisala","year":"2014","journal-title":"Hypertension"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpy104","article-title":"Differential Associations of Diastolic and Systolic Pressures With Cerebral Measures in Older Individuals With Mild Cognitive Impairment","volume":"31","author":"Shokouhi","year":"2018","journal-title":"Am J Hypertens"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife Hypertention and 20-Year Cognitive Change: The Atherosclerosis Risk in Communities Neurocognitive Study","volume":"21287","author":"Gottesman","year":"2014","journal-title":"JAMA Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000046","article-title":"Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"45","author":"Meschia","year":"2014","journal-title":"Stroke"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.10575","article-title":"Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia","volume":"322","author":"Walker","year":"2019","journal-title":"JAMA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00005","article-title":"Hypertension and the Risk of Dementia","volume":"7","author":"Sierra","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.14800\/rci.774","article-title":"Vascular Protective Effects of Angiotensin Receptor Blockers: Beyond Blood Pressure","volume":"2","author":"Artham","year":"2015","journal-title":"Receptors Clin Investig"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1042\/CS20150350","article-title":"Renin-Angiotensin System as a Potential Therapeutic Target in Stroke and Retinopathy: Experimental and Clinical Evidence","volume":"130","author":"Fouda","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-020-00231-y","article-title":"Brain Angiotensin II and Angiotensin IV Receptors as Potential Alzheimer\u2019s Disease Therapeutic Targets","volume":"42","author":"Royea","year":"2020","journal-title":"Geroscience"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030876","article-title":"Within the Brain: The Renin Angiotensin System","volume":"19","author":"Jackson","year":"2018","journal-title":"Ergul A Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.118.248831","article-title":"Molecular Basis of the Brain Renin Angiotensin System in Cardiovascular and Neurologic Disorders: Uncovering a Key Role for the Astroglial Angiotensin Type 1 Receptor AT1R","volume":"366","author":"Haspula","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105922","article-title":"Functions of the (Pro) Renin Receptor (Atp6ap2) at Molecular and System Levels: Pathological Implications in Hypertension, Renal and Brain Development, Inflammation, and Fibrosis","volume":"173","author":"Hoffmann","year":"2021","journal-title":"Pharmacol Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and Treatment of Low-Renin Hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2019.08.003","article-title":"Low-Renin Hypertension","volume":"48","author":"Athimulam","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/bs.vh.2018.10.006","article-title":"Primary Aldosteronism: Present and Future","volume":"109","author":"Funder","year":"2019","journal-title":"Vitam Horm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of Mineralocorticoid Action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1176","article-title":"The Development of Hypertension and Hyperaldosteronism in a Rodent Model of Life-Long Obesity","volume":"153","author":"Northcott","year":"2012","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e12460","DOI":"10.1111\/micc.12460","article-title":"Mineralocorticoid Receptor Antagonism Prevents Obesity-Induced Cerebral Artery Remodeling and Reduces White Matter Injury in Rats","volume":"25","author":"Pires","year":"2018","journal-title":"Microcirculation"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.02.034","article-title":"Aldosterone-Induced Oxidative Stress and Inflammation in the Brain Are Mediated by the Endothelial Cell Mineralocorticoid Receptor","volume":"1637","author":"Dinh","year":"2016","journal-title":"Brain Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.5.673","article-title":"Aldosterone Synthase (CYP11B2) Gene Polymorphism and Cerebral White Matter Hyperintensities","volume":"56","author":"Verpillat","year":"2001","journal-title":"Neurology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jhh.2015.21","article-title":"Potential Effects of Age on Screening for Primary Aldosteronism","volume":"30","author":"Luo","year":"2016","journal-title":"J Hum Hypertens"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0022-510x(93)90041-v","article-title":"A Semiquantative Rating Scale for the Assessment of Signal Hyperintensities on Magnetic Resonance Imaging","volume":"114","author":"Scheltens","year":"1993","journal-title":"J Neurol Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15006","article-title":"Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium: The Multi-Ethnic Study of Atherosclerosis","volume":"76","author":"Inoue","year":"2020","journal-title":"Hypertension"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.653964","article-title":"Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure","volume":"115","author":"G\u00fcder","year":"2007","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0047","article-title":"Renal Impairment Is Closely Associated With Plasma Aldosterone Concentration in Patients With Primary Aldosteronism","volume":"181","author":"Kawashima","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(90)90215-e","article-title":"Mineralocorticoid Receptor Gene Expression in the Gastrointestinal Tract: Distribution and Ontogeny","volume":"36","author":"Fuller","year":"1990","journal-title":"J Steroid Biochem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/bs.vh.2018.09.004","article-title":"Mechanisms of Mineralocorticoid Receptor Signaling","volume":"109","author":"Fuller","year":"2019","journal-title":"Vitam Horm"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-16-0660","article-title":"30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The Brain Mineralocorticoid Receptor: A Saga in Three Episodes","volume":"234","author":"Joe\u00a8ls","year":"2017","journal-title":"J Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322011000300020","article-title":"Effects of Spironolactone in Spontaneously Hypertensive Adult Rats Subjected to High Salt Intake","volume":"66","author":"Baldo","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.56.7.921","article-title":"Longitudinal Study of Blood Pressure and White Matter Hyperintensities: The EVA MRI Cohort","volume":"56","author":"Dufouil","year":"2001","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.961052","article-title":"Antihypertensive Treatment and Change in Blood Pressure Are Associated With the Progression of White Matter Lesion Volumes: The Three-City (3c)-Dijon Magnetic Resonance Imaging Study","volume":"123","author":"Godin","year":"2011","journal-title":"Circulation"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.025139","article-title":"Diastolic Blood Pressure Is Associated With Regional White Matter Lesion Load: The Northern Manhattan Study","volume":"51","author":"Caunca","year":"2020","journal-title":"Stroke"},{"key":"B48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular Events and Target Organ Damage in Primary Aldosteronism Compared With Essential Hypertension: A Systematic Review and Meta-Analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation Through a Placental Growth Factor-Dependent Mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J Am Heart Assoc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.753074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T09:39:53Z","timestamp":1637228393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.753074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":50,"alternative-id":["10.3389\/fendo.2021.753074"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.753074","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"article-number":"753074"}}